BIO Events
BIO 2026: 340B faces growing calls for transparency, patient-focused reform
Experts at the BIO International Convention examine the growth of the 340B drug pricing program, duplicate discounts, patient access, and calls for greater transparency. “The ...
Read More
Latest News
LATEST STORIES
BIO Events
BIO 2026: 340B faces growing calls for transparency, patient-focused reform
Experts at the BIO International Convention examine the growth of the 340B drug pricing program, duplicate discounts, patient access, and calls for greater transparency. “The ...
BIO Events
BIO 2026: ‘I am alive today because of biotech’
From sickle cell disease to multiple sclerosis and childhood leukemia, patients and advocates reflected on becoming pioneers in therapies that are changing medicine. For most ...
BIO Events
BIO 2026: Biotech threatened by pressures on patent protection
At a time when U.S. biotech leadership is being challenged, the patent system that enables life-saving innovations is beset by a toxic stew of challenges. ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIO 2026: 340B faces growing calls for transparency, patient-focused reform
Experts at the BIO International Convention examine the growth of the 340B drug pricing program, duplicate discounts, patient access, and calls for greater transparency. “The ...
Read More
BIO 2026: ‘I am alive today because of biotech’
From sickle cell disease to multiple sclerosis and childhood leukemia, patients and advocates reflected on becoming pioneers in therapies that are changing medicine. For most ...
Read More